Jiwa Bio-Pharm Holdings Ltd. announced that with effect from the close of the Offer on 23 September 2013: Mr. Lau Yau Bor, Mr. Lau Kin Tung and Madam Chan Hing Ming resigned as the executive Directors; and Mr. Chiu Wai Piu, Mr. Choy Ping Sheung and Mr. Fung Tze Wa resigned as the independent non-executive Directors. With effect immediately following the change in directorship the audit committee of the Company comprises Mr. Lee Cheuk Yin, Dannis (Chairman), Mr. Gao Guanjiang and Mr. Chen Xuejun; the remuneration committee of the Company comprises Mr. Gao Guanjiang (Chairman), Professor Wilton Chi Wai Chau and Mr. Liu Lailin; and the nomination committee of the Company comprises Mr. Zhou Xuzhou (Chairman),
Professor Wilton Chi Wai Chau and Mr. Lee Cheuk Yin, Dannis. With effect from the close of the Offer on 23 September 2013: Mr. Zhou Xuzhou, an executive Director, has been appointed as chairman of the Board; and Ms. Zhou Wen Chuan, an executive Director, has been appointed as chief executive officer of the company. The resignation of the resigning Directors was due to the change in control of the company upon completion of the share purchase agreement.